WHO-GMP,EU-GMP and Health Canada certified 3-Star pharmaceutical export house
We are India’s leading pharmaceutical formulations manufacturer and exporter, having an in-house R&D Centre equipped with advanced facilities with highly qualified and experienced scientists. Our global team of over 700 top-notch healthcare experts and professionals is committed to the ethos of “Supporting Life Worldwide.” Based in Ahmedabad, India, BioMatrix has started its modest journey in 2007 and today it has flourished as one of India’s frontline pharmaceutical manufacturing companies with committed to offering inclusive healthcare to the world .
BioMatrix’s business is spread across four regions and more than 40+ nations, serving satisfied customers in Africa, Latin America, CIS and Southeast Asia. In the near future, we intend to enter European region.
The company’s manufacturing facility is WHO-GMP,EU-GMP and Health Canada certified and we comply with US-FDA, UK-MHRA and ANVISA regulatory requirements. Apart from this, we possess several other certifications that benchmark our products for their global quality standards, safety and efficacy.
As of 2025, BioMatrix has over 1000 product registrations with more than 500 products under registration across Europe, SEA, CIS, LATAM , GCC and African Countries.
At BioMatrix, we go beyond the convention of Health is Wealth and aim for total wellness and wellbeing of the world, thus empowering mankind to lead not only healthy but happy and productive lives. Our core values of Honesty, Integrity, Dedication and Hard work further strengthen our commitment to offer holistic wellness to the world. Aligned with this corporate ethos, our products offer safe and effective treatments for a wide range of diseases, illnesses and disorders that trouble humanity. By curing, we care and by treating the anomalies, we create a healthcare ecosystem which benefits millions of patients worldwide.
Inclusive and affordable healthcare is our stated mission backed by an actionable agenda that delivers results. Thus, each day of our corporate life, we live by our motto of supporting life worldwide.
Over the years, we have ploughed back monetary profits to fund our growth and expansion, and that in turn has increased our operational profitability. Thus, BioMatrix’s integrated profit and re-investment cycle has created a standalone model of a self-reliant, strong and sustainable financial ecosystem.
Our customers spread all over the world laud our robust financial standing, often referring to BioMatrix as a safe and reliable long-term business partner.
We are changing too with time, technology and innovations in healthcare and pharmaceutical industry. However, the major factor which inspires us to change and update time to time is our customer requirements. We constantly update ourselves to match our customer requirements. To continue to thrive in the healthcare industry, we live and breathe this ultimate vision.
Read more
To become a leading pharmaceutical company in India and a significant global player by providing
high quality, affordable and innovative medicines
for healthier lives.
BioMatrix Healthcare Pvt. Ltd. truly understands the need of quality healthcare in India and
across the globe. We want to make this world a healthier place to live in. We are
committed to offer world-class healthcare and pharmaceutical products for healthier
lives.
To provide affordable and innovative medicines to all for healthier lives.
Through hard work, perseverance and persistent strategies, BioMatrix wishes to translate its mission into a reality by extending a helping hand to
the medical fraternity in their noble cause of treating the masses at an affordable cost and
to make “Healthcare for all” a reality through the humble contribution of world-class yet
affordable medicines.
We are committed to provide total customer satisfaction and achieve leadership in chosen
markets, products and services across the globe through excellence in technology based on
world class research and development.
We at BioMatrix believe in high ethical standards in our practices.
We are thrilled to announce that our Oral Solids, Liquids and Dry syrup facility has received EUGMP approval! This achievement is a testament to unwavering dedication and commitment of our Team.
Read more
It was a phenomenal experience for BioMatrix to be a part of Iphex 2024 and to interact with multiple international delegates to explore collaboration opportunities for improved healthcare. IPHEX, organised by PHARMEXCIL is one of the largest exhibitions showcasing Indian pharmaceutical products and technologies to a global audience.
Read more
We had a great time attending and exhibiting at CPHI Worldwide in Milan. It’s been an amazing three days of networking, learning and growth. A huge thank you to everyone who visited us and to our dedicated team for their tireless efforts that made all of this possible. We’re excited about the future collaborations and innovations ahead. Stay connected with us for more updates and exciting projects.
Read more
Exciting Milestone Achieved! We’re thrilled to share that BioMatrix Healthcare Pvt. Ltd. has received site approval from Health Canada! A big kudos to our incredible team for their unwavering dedication and expertise. This milestone reflects our commitment to quality and innovation in healthcare! Here’s to many more milestones ahead!.
Read more
BioMatrix had an incredible experience at Iphex 2025, engaging with international delegates and exploring impactful collaborations for a healthier future. This year’s participation gave us the opportunity to strengthen global connections, showcase our commitment to quality healthcare, and open new doors for partnerships across continents.
Read more
We proudly announce a regulatory milestone with site approval from the Food and Drug Administration (FDA), Philippines.This approval reflects our continued commitment to maintaining global quality standards and ensuring the safety and efficacy of our products.
Read more
We are pleased to announce the successful approval from the Iraqi Ministry of Health, marking another important step in our global regulatory expansion. This achievement strengthens our presence in the Middle East and reflects our commitment to meeting international quality and regulatory standards.
Read more
BioMatrix Healthcare marked a strong presence at CPHI Frankfurt 2025, engaging with global leaders and collaborators to drive innovation and excellence in pharmaceuticals.
Read more
We are proud to announce the approval of our first European Market Authorization (MA) for Sitagliptin Tablets (25 mg, 50 mg & 100 mg). This achievement marks a major step forward in our global expansion journey and reflects the hard work, dedication, and excellence of our entire team.
Read more
